C

CeleScreen

10 employees

CeleScreen develops an innovative technology for the rapid screening of xenobiotics toxicity.

Basic info

Industry

personal care product manufacturing

Sectors

toxicology
REACH
systemic toxicity
C. elegans
reprotoxicity
lead optimization
drug design
Cosmetics
teratogenicity

Date founded

2015

Funding rounds raised

C

CeleScreen raised undisclosed on July 1, 2014

Investors: Agoranov

FAQ